Unexpectedly, treatment with bisphosphonates increased cLuc activity (Figure 7D) and expression of EWS marker NKX2.2 (Figure 7E), suggesting that ZA and ALD favored tumor proliferation. Here, NKX2-2 is linked to neoplasm.